FDA grants EUA for Pfizer-BioNTech’s Covid-19 booster in children
The expanded EUA for use of booster dose in children is based on the findings from a Phase II/III clinical…
Infectious Diseases
Latest in
Infectious Diseases
FDA declines to grant EUA for antidepressant to treat Covid-19
The data was inadequate to conclude that the drug was effective in preventing disease progression, FDA noted.
EC to terminate Covid-19 vaccine deal with Valneva
The EC can terminate the agreement if the vaccine does not obtain marketing authorisation from EMA by the end of…
Pfizer and BioNTech amend Covid-19 vaccine supply deal with EC
The vaccine doses planned to be supplied between June and August will now be delivered from September to Q4 of…
Takeda announces 11.6% reported revenue growth in FY2021
For the fiscal year, the operating cash flow witnessed a 11.1% rise to $8.63bn (JPY1,123.1bn).
Sound Pharmaceuticals receives NIH grant for Covid-19 therapy development
The grant will support two trials of ebselen in 120 adult subjects with moderate or severe Covid-19.
FDA grants approval for Lilly-Incyte’s Covid-19 treatment
The approval is based on findings from two Phase III clinical trials, ACTT-2 and COV-BARRIER.
API and University of Waterloo to develop coronavirus drugs
This alliance is the third academic-industry partnership of API this year to develop therapies against viral variants.